APA (7th ed.) Citation

BH, R., YKO, T., EM, G., C, A., DJ, C., J, R., . . . RB, H. (2021). Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): A double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet (London, England), 397(10289), 2070. https://doi.org/10.1016/S0140-6736(21)00578-X

Chicago Style (17th ed.) Citation

BH, Rovin, et al. "Efficacy and Safety of Voclosporin Versus Placebo for Lupus Nephritis (AURORA 1): A Double-blind, Randomised, Multicentre, Placebo-controlled, Phase 3 Trial." Lancet (London, England) 397, no. 10289 (2021): 2070. https://doi.org/10.1016/S0140-6736(21)00578-X.

MLA (9th ed.) Citation

BH, Rovin, et al. "Efficacy and Safety of Voclosporin Versus Placebo for Lupus Nephritis (AURORA 1): A Double-blind, Randomised, Multicentre, Placebo-controlled, Phase 3 Trial." Lancet (London, England), vol. 397, no. 10289, 2021, p. 2070, https://doi.org/10.1016/S0140-6736(21)00578-X.